PET/MRI
Showing 1 - 25 of >10,000
Rectal Cancer Trial (Chemoradiation treatment, 18FDG-PET/MRI scan)
Not yet recruiting
- Rectal Cancer
- Chemoradiation treatment
- 18FDG-PET/MRI scan
- (no location specified)
Sep 26, 2023
Contribution of PET/MRI in Locally Advanced Cervical Cancer
Not yet recruiting
- Cervical Cancer
- 18-FDG PET-MRI
-
Strasbourg, FranceInstitut de cancérologie Strasbourg Europe
Oct 12, 2023
Cardiac Sarcoidosis Trial (PET/MRI)
Not yet recruiting
- Cardiac Sarcoidosis
- PET/MRI
- (no location specified)
Jul 26, 2023
Hepatocellular Carcinoma Trial in Aarhus (18F-FDGal PET/CT or PET/MRI)
Not yet recruiting
- Hepatocellular Carcinoma
- 18F-FDGal PET/CT or PET/MRI
-
Aarhus, DenmarkAarhus University Hospital
May 15, 2023
Esophagogastric Cancer Trial in Toronto (PET-MRI)
Recruiting
- Esophagogastric Cancer
- PET-MRI
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 5, 2023
18F-fluorocholine, Positron-Emission Tomography, Hyperparathyroidism, Primary Trial in Toronto ([F-18]-FCH PET/MRI)
Active, not recruiting
- 18F-fluorocholine
- +2 more
- [F-18]-FCH PET/MRI
-
Toronto, Ont, CanadaUHN
Dec 9, 2022
Esophageal Cancer Trial in Taoyuan (PET/MRI)
Completed
- Esophageal Cancer
- PET/MRI
-
Taoyuan, TaiwanLinkou Chang Gung Memorial Hospital
May 9, 2023
Esophageal Cancer Trial in Taoyuan (PET/MRI)
Completed
- Esophageal Cancer
- PET/MRI
-
Taoyuan, TaiwanLinkou Chang Gung Memorial Hospital
May 9, 2023
Breast Cancer Trial in Madison (drug, device, other)
Not yet recruiting
- Breast Cancer
- 18F-fluorofuranylnorprogesterone
- +4 more
-
Madison, WisconsinUW Carbone Cancer Center
Oct 11, 2023
Response After Neoadjuvant Treatment of Locally Advanced Rectal
Not yet recruiting
- Rectal Cancer
- PET-MRI
-
Strasbourg, FranceInstitut de cancérologie Strasbourg Europe
Mar 15, 2023
Prostate Cancer Trial (Piflufolastat F 18 Intravenous Solution [PYLARIFY])
Not yet recruiting
- Prostate Cancer
- Piflufolastat F 18 Intravenous Solution [PYLARIFY]
- (no location specified)
Oct 3, 2023
Hepatocellular Carcinoma Trial (Radiolabelled tracer, 68Gallium-FAPI-46 PET/MRI)
Not yet recruiting
- Hepatocellular Carcinoma
- Radiolabelled tracer, 68Gallium-FAPI-46 PET/MRI
- (no location specified)
Jan 8, 2023
Hepatocellular Carcinoma Trial in Birmingham ([68Ga]DOTATATE-PET/MRI)
Completed
- Hepatocellular Carcinoma
-
Birmingham, AlabamaUniversity of Alabama at Birmingham Medical Center
Dec 16, 2022
Esophageal Cancer, Esophageal Tumors Trial in Milano (hybrid PET/MRI)
Recruiting
- Esophageal Cancer
- Esophageal Neoplasms
- hybrid PET/MRI
-
Milano, ItalyDeaprtment of Radiology, IRCCS Ospedale San Raffaele
Jan 24, 2023
Brain Tumor, Pediatric Trial (PET-MRI)
Not yet recruiting
- Brain Tumor, Pediatric
- PET-MRI
- (no location specified)
Sep 21, 2022
High Grade Glioma Trial in Birmingham (O-(2-[18F]Fluoroethyl)-L-tyrosine, [18F]-FET with PET/MRI)
Not yet recruiting
- High Grade Glioma
- O-(2-[18F]Fluoroethyl)-L-tyrosine, [18F]-FET with PET/MRI
-
Birmingham, AlabamaUAB
Nov 21, 2022
HER2-positive Breast Cancer Trial in Birmingham ([18F]FMISO PET/MRI imaging)
Recruiting
- HER2-positive Breast Cancer
- [18F]FMISO PET/MRI imaging
-
Birmingham, AlabamaThe University of Alabama at Birmingham
Dec 8, 2022
Perfusion and Anatomy Measures of Heart With MRI and Combined
Not yet recruiting
- Coronary Artery Disease
- (no location specified)
Nov 1, 2022
Head Neck Cancer Trial (PET-MRI)
Not yet recruiting
- Head and Neck Cancer
- PET-MRI
- (no location specified)
Sep 4, 2023
Stratifying Endometrial Cancer Patients UsingPET/MRI Prognostic
Recruiting
- Endometrium Cancer
-
Milano, ItalyIRCCS Ospedale San Raffaele
Jan 24, 2023
Hepatocellular Carcinoma Trial in Toronto (PET MRI)
Active, not recruiting
- Hepatocellular Carcinoma
- PET MRI
-
Toronto, Ontario, CanadaToronto General Hospital
Oct 31, 2022
Depression Trial in Stony Brook (Escitalopram, Placebo)
Completed
- Depression
- Escitalopram
- Placebo
-
Stony Brook, New YorkStony Brook University Hospital
Dec 14, 2022